NEW YORK, Jan. 5 (GenomeWeb News) - Galapagos has licensed asthma and allergy drug targets to GlaxoSmithKline and will identify further targets for the drug maker, the Mechelen, Belgium-based company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.
23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.